Mode
Text Size
Log in / Sign up
N/A Completed N=989 Randomized Treatment

SPECS: Safe Pediatric Euglycemia in Cardiac Surgery

Source: ClinicalTrials.gov NCT00443599 ↗
Enrolled (actual)
989
Serious AEs
2.1%
Results posted
Mar 2014
Primary outcomePrimary: Incidence of Nosocomial Infections in the Cardiac ICU — 8.6; 9.9 infections / 1000 pt days

Summary

Critically ill children, including children undergoing heart surgery, commonly develop elevated blood glucose (also known as "blood sugar") levels during their illness, which can lead to poor health outcomes and an increased risk of death. This study will examine the effectiveness of maintaining normal blood glucose levels at decreasing infections and improving recovery in young children undergoing heart surgery.

Outcome Measures

OutcomeResultp-value
PRIMARY
Incidence of Nosocomial Infections in the Cardiac ICU
8.6; 9.9
SECONDARY
Cardiac Index (CI)
2.0; 1.8
SECONDARY
Duration of ICU Stay
3; 3
SECONDARY
Duration of Hospital Stay
8; 7
SECONDARY
Duration of Endotracheal Intubation
3; 2
SECONDARY
Mortality at Hospital Discharge.
11; 11
SECONDARY
Mortality at 30 Days.
5; 6
SECONDARY
Cardiac Function
2; 2
SECONDARY
Immune Function
3.1; 4.3
SECONDARY
Endocrine Function
84; 75
SECONDARY
Nutritional Status
41; 38
SECONDARY
Neurodevelopmental Evaluation, Cognitive
100.2; 100.8
SECONDARY
Neurodevelopmental Evaluation, Language
94.7; 94.7
SECONDARY
Neurodevelopmental Evaluation, Motor
87.2; 88.9

Eligibility Criteria

Inclusion Criteria

  • Undergoing heart surgery with cardiopulmonary bypass
  • Recovering in the Cardiac ICU

Exclusion Criteria

  • Enrolled in another interventional clinical trial with related study outcomes
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00443599). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search